Pulmonary Hypertension News Forums › Forums › Research and Development › Range of Clinical Trials Testing INOpulse System for PAH, PH-linked Lung Diseases, Bellerophon Announces

  • Research & Development

    Range of Clinical Trials Testing INOpulse System for PAH, PH-linked Lung Diseases, Bellerophon Announces

    Posted by Pulmonary Hypertension News Moderator on November 27, 2018 at 1:48 pm

    An update by Bellerophon details the upcoming or ongoing clinical trials of INOpulse inhaled nitric oxide in treating PAH and PH-associated lung diseases. Learn about this here.

    What do you think about this news?

    replied 7 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .